Clinical Trial Update: Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on transplantation of microbes for metabolic syndrome and non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Diabetes Mellitus, Non-alcoholic Fatty Liver Disease | Phase 1, Phase 2 | Status: COMPLETED